Skip to main content
Log in

Preparation and Administration of Chemotherapy

Haematological Consequences for Hospital-Based Nurses

  • Toxicology Experience Report
  • Published:
Medical Toxicology and Adverse Drug Experience Aims and scope Submit manuscript

Summary

This study examined the question of whether previous exposure to cytostatic drugs by oncology nurses was sufficient to lead to haematological phenotypical subclinical abnormalities which had previously been identified in a population of patients who had received chemotherapy as an adjuvant to breast surgery. A comparison of baseline haematological parameters, and the results of a prednisolone stimulation test, was made between nurses regularly coming into contact with such agents and an age-adjusted group of nurses who had not been exposed. Although there is a persistent trend toward lower neutrophils, platelets, monocytes and neutrophil reserves in the nurses who handled antineoplastic agents, a statistically significant decrement in these parameters was not identified. Such a finding should help to reassure individuals who have had similar exposure, but does not negate the importance of following published recommended guidelines for the handling and dispensing of antineoplastic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Corder MP, Jochimsen PR. Marrow neutrophil reserve after adjuvant chemotherapy for cancer of the breast. Cancer 49: 2455–2458, 1981

    Article  Google Scholar 

  • Council on Scientifíc Affairs. Guidelines for handling parenteral antineoplastics. Journal of the American Medical Association 253: 1590–1592, 1985

    Article  Google Scholar 

  • Cream JJ. Prednisolone induced granulocytosis. British Journal of Haematology 15: 259–267, 1968

    Article  PubMed  CAS  Google Scholar 

  • Falck K, Grohn P, Sorsa M, et al. Mutagenicity in urine or nurses handling systolic drugs. Lancet 1: 1250–1251, 1979

    Article  PubMed  CAS  Google Scholar 

  • Goodyear MOE, Mackay IR, Russell IS. Delayed recovery of peripheral blood cell numbers after adjuvant cytotoxic chemotherapy for stage II breast cancer. Cancer, Chemotherapy and Pharmacology 7: 37–40, 1981

    Article  CAS  Google Scholar 

  • Jordan DK, Patil SR, Jochimsen PR, Lachenbruch PA, Corder MP. Sister chromatid exchange analysis in nurses handling antineoplastic drugs. Cancer Investigation 4: 101–107, 1986

    Article  PubMed  CAS  Google Scholar 

  • Selevan SG, Lindbohm M, Sci CP, Hornung RW, Hemminke K. A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. New England Journal of Medicine 313: 1173–1178, 1985

    Article  PubMed  CAS  Google Scholar 

  • Stellman JM, Zoloth SR. Cancer chemotherapeutic agents as occupational hazards: a literature review. Cancer Investigation 4(2): 127–135, 1986

    Article  PubMed  CAS  Google Scholar 

  • Venitt S, Croften-Sleigh C, Hunt J, Speechley N, Buggs K. Monitoring exposure of nursing and pharmacy personnel to cytotoxic drugs: urinary mutation assays and urinary platinum as markers of absorption. Lancet 1: 74–77, 1984

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jochimsen, P.R., Corder, M.P., Lachenbruch, P.A. et al. Preparation and Administration of Chemotherapy. Dis-Manage-Health-Outcomes 3, 59–63 (1988). https://doi.org/10.1007/BF03259931

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259931

Keywords

Navigation